An interventional study of Occupation-Based Immersive Virtual Reality Rehabilitation in Stroke and Upper Extremity Paresis, sponsored by Democritus University of Thrace. Recruiting at 2 sites in Greece. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Democritus University of Thrace · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 55 studies in Stroke with a site in Greece — 13 open to participants now, 18 under way, 3 of them phase 3. Stroke · Greece.
Among the 55 studies in Stroke with a site in Greece, this one is the 40th largest by planned enrollment of the 44 interventional ones that give a count, is one of 3 that started in 2026, is one of 19 with no phase, reaches primary completion later than 11 of the 17 other live ones, and was the 55th registered.
8,269 studies on the registry are indexed under Stroke; 2,062 are open to participants now.
Browse Stroke studies →13 of the 55 studies in Stroke with a site in Greece are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Greece, Argentina, Australia and 35 more countries
Ages 50+
Arnaoutis Stylianos · Sites in Greece
Ages 18+
University of Ioannina · Sites in Greece
Ages 15–70
National and Kapodistrian University of Athens · Sites in Greece
Ages 40–100
University Hospital, Ioannina · Sites in Greece
Ages 18–100 · Healthy volunteers
A study can be open while its sites in Greece have not opened yet or have stopped. Only those recruiting at a site in Greece →
Of the 1,418 Stroke studies recruiting now, 696 (49%) set no upper age limit and 282 (20%) stop at 75 or younger; 77 take children under 18; 196 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
55 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 49 across 6,036 interventional studies indexed under Stroke.
Median enrollment 920 across the 44 interventional studies, 700 across the 11 observational. Of the 34 that completed or were terminated, 14 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
26 of 55 have an industry lead sponsor. The 10 most frequent:
Democritus University of Thrace is the lead sponsor of 71 studies on the registry; 9 are open to participants now.
Democritus University of Thrace has 1 study filed under Stroke — fewer than ten, so there is no comparison to draw.
2 of the studies in Stroke with a site in Greece that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05494034National and Kapodistrian University of AthensYield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke. | 2027-01-01 |
| NCT07936461Democritus University of ThraceFeasibility of Occupation-Based Immersive Virtual Reality for Upper-Limb Rehabilitation After Stroke | 2027-07-20 |
Add all 2 to your calendar (.ics) → With an account.
Among the 55 studies in Stroke with a site in Greece, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This ongoing, single-group pilot feasibility study aims to evaluate the feasibility, usability, and acceptability of an occupation-based immersive virtual reality (IVR) rehabilitation program for adults with stroke-related upper-limb impairment. The study has an anticipated enrollment of 20 participants, of whom eight were enrolled during the initial recruitment period.
The intervention consists of 12 supervised sessions per participant, each including approximately 30 minutes of virtual activities delivered through two custom-developed IVR applications, Virtual Gardening and Virtual Painting, using a Meta Quest 2 head-mounted display (HMD). The intervention is provided as an adjunct to usual occupational therapy.
The study examines intervention completion, session delivery, gameplay duration, technical interruptions, safety, user satisfaction, symptoms associated with virtual reality exposure, and participation during rehabilitation sessions. Upper-limb motor function and independence in activities of daily living are also assessed as exploratory clinical outcomes.
The primary aim is to determine whether this occupation-based IVR rehabilitation program can be feasibly implemented in clinical practice and to identify areas for improvement before larger-scale studies. The study is not designed to establish the effectiveness of the intervention compared with conventional rehabilitation.
The intervention was developed through a stakeholder-informed process that incorporated occupational therapists' perspectives, stroke survivors' activity preferences, task-level characterization, and preliminary usability evaluation. Two custom-developed IVR applications, Virtual Gardening and Virtual Painting, were implemented using Unity and delivered through a Meta Quest 2 HMD.
This ongoing, single-group pilot feasibility study has an anticipated enrollment of 20 adults with stroke-related upper-limb impairments. Eight participants were enrolled during the initial recruitment period, and recruitment is continuing toward the planned sample size. Participants are scheduled to receive 12 supervised IVR sessions as an adjunct to their usual occupational therapy.
Each session is planned to include approximately 30 minutes of virtual activities: 10 minutes of structured Gardening, 10 minutes of structured Painting, 5 minutes of free Gardening, and 5 minutes of free Painting. Rest breaks and therapist assistance are provided according to individual needs.
The applications include graded activities involving reaching, object interaction, upper-limb coordination, and creative engagement. Different interaction modes, including affected-hand interaction and mirrored control using the unaffected hand, are available to accommodate individual functional abilities. All activities are performed in a seated position under therapist supervision.
Exploratory clinical outcomes include upper-limb motor impairment, assessed using the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE), and independence in activities of daily living, assessed using the Barthel Index. Both measures are administered at baseline (before the first intervention session) and after completion of session 12.
User satisfaction and experience are assessed using the User Satisfaction Evaluation Questionnaire (USEQ), while symptoms associated with virtual reality exposure are monitored using the Simulator Sickness Questionnaire (SSQ). Both questionnaires are administered after intervention sessions 1, 6, and 12.
Participation during rehabilitation is assessed by the therapist using the Pittsburgh Rehabilitation Participation Scale (PRPS) during each intervention session (sessions 1-12).
The study is conducted in supervised rehabilitation settings in Larissa, Greece. Its primary purpose is to examine the feasibility, usability, safety, and acceptability of the occupation-based IVR intervention and to inform the design of future larger-scale investigations. As a single-group pilot feasibility study without a control group, it is not designed to establish treatment efficacy or comparative effectiveness against conventional rehabilitation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive a 12-session, therapist-supervised, occupation-based IVR rehabilitation program as an adjunct to conventional occupational therapy. The program includes two custom-developed virtual activities, Virtual Gardening and Virtual Painting, delivered using a Meta Quest 2. Activities include structured, graded tasks and free exploration, with interaction modes adapted to participants' upper-limb functional abilities. Participants continue to receive their usual occupational therapy throughout the study.
Other: Occupation-Based Immersive Virtual Reality Rehabilitation
The intervention consists of 12 supervised immersive virtual reality (IVR) sessions using two occupation-based applications: Virtual Gardening and Virtual Painting. Each session is planned to include approximately 30 minutes of virtual activities: 10 minutes of structured Gardening, 10 minutes of structured Painting, 5 minutes of free Gardening, and 5 minutes of free Painting. Gardening activities include reaching toward leaves, harvesting virtual olives, planting seeds, and watering plants. Painting activities include tracing geometric and representational shapes and creating drawings using virtual brushes and colours. The applications provide graded task difficulty, affected-hand interaction, mirrored control using the unaffected hand, and free exploration. Participants interact with the virtual environment using a Meta Quest 2 head-mounted display and controllers while seated, under therapist supervision. Rest breaks and assistance are provided according to individual needs.
Intervention Completion Rate
Percentage of enrolled participants who completed the planned 12-session immersive virtual reality rehabilitation program. Calculated as the number of participants completing the intervention divided by the total number enrolled, multiplied by 100.
Time frame: From enrollment to completion of the 12-session intervention (approximately 4 weeks per participant).
Session Delivery Rate
Percentage of planned immersive virtual reality rehabilitation sessions that were delivered. Calculated as the number of sessions delivered divided by the total number of sessions planned across enrolled participants, multiplied by 100.
Time frame: Throughout the 12-session intervention period (approximately 4 weeks per participant).
Upper-Limb Motor Impairment - Fugl-Meyer Assessment for the Upper Extremity (FMA-UE)
Change in upper-limb motor impairment assessed using the FMA-UE. The motor function subscale ranges from 0 to 66, with higher scores indicating better upper-limb motor performance. Changes from baseline to the post-intervention assessment will be examined.
Time frame: Baseline (before intervention) and after session 12 (approximately 4 weeks).
Independence in Activities of Daily Living - Barthel Index(BI)
Change in independence in basic activities of daily living assessed using the BI. Total scores range from 0 to 100, with higher scores indicating greater functional independence. Changes from baseline to the post-intervention assessment will be examined.
Time frame: Baseline (before intervention) and after session 12 (approximately 4 weeks).
User Satisfaction - User Satisfaction Evaluation Questionnaire (USEQ)
Participant-reported satisfaction and user experience with immersive virtual reality, assessed using the USEQ. Responses are rated on a five-point Likert scale, with higher scores on positively worded items indicating greater satisfaction. Discomfort-related items are interpreted separately.
Time frame: After session 1, after session 6 (approximately 2 weeks), and after session 12 (approximately 4 weeks).
Simulator Sickness Symptoms - Simulator Sickness Questionnaire (SSQ)
Symptoms associated with virtual reality exposure, including nausea, oculomotor discomfort, and disorientation, assessed using the SSQ. Higher scores indicate greater symptom severity.
Time frame: After session 1, after session 6 (approximately 2 weeks), and after session 12 (approximately 4 weeks).
Rehabilitation Participation - Pittsburgh Rehabilitation Participation Scale (PRPS)
Therapist-rated participation during immersive virtual reality rehabilitation sessions, assessed using the PRPS. Scores range from 1 to 6, with higher scores indicating greater participation.
Time frame: During each intervention session (sessions 1-12), over approximately 4 weeks per participant.
Documented Gameplay Duration
Duration of active immersive virtual reality gameplay, recorded in minutes during each intervention session. Descriptive statistics will summarize the documented gameplay duration across delivered sessions.
Time frame: During each delivered intervention session (sessions 1-12), over approximately 4 weeks per participant.
Technical Interruptions
Number and proportion of delivered immersive virtual reality sessions affected by technical interruptions, including headset tracking problems, controller connectivity issues, or signal loss.
Time frame: During each delivered intervention session (sessions 1-12), over approximately 4 weeks per participant.
Adverse Events
Number and description of adverse events documented during the immersive virtual reality intervention, including symptoms or incidents potentially associated with virtual reality exposure. Events will be summarized descriptively.
Time frame: From the first intervention session through completion of session 12, approximately 4 weeks per participant.
Plan to share: No — The individual participant data generated during this study will not be publicly shared due to participant confidentiality considerations and the small sample size. Aggregated study findings will be reported in the resulting publications.
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Jul 2027, 18 months after the start.
Of 3,117 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 18 months is below that.
Counting every sponsor, half of 3,261 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Democritus University of Thrace